help button home button Endocrine Society Endocrinology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

Endocrinology, doi:10.1210/en.2002-0214
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
144/9/4097    most recent
Author Manuscript (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Gao, X.-M.
Right arrow Articles by Du, X.-J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Gao, X.-M.
Right arrow Articles by Du, X.-J.
Endocrinology Vol. 144, No. 9 4097-4105
Copyright © 2003 by The Endocrine Society

Sex Hormones and Cardiomyopathic Phenotype Induced by Cardiac ß2-Adrenergic Receptor Overexpression

Xiao-Ming Gao, Alex Agrotis, Dominic J. Autelitano, Elodie Percy, Elizabeth A. Woodcock, Garry L. Jennings, Anthony M. Dart and Xiao-Jun Du

Baker Heart Research Institute and Alfred Heart Centre, Alfred Hospital, Melbourne, Victoria 8008, Australia

Address all correspondence and requests for reprints to: Xiao-Jun Du, Baker Medical Research Institute, PO Box 6492, St Kilda Road Central, Melbourne, Victoria 8008, Australia. E-mail: xiaojun.du{at}baker.edu.au.

Sex differences in cardiomyopathic phenotype and the role of gonadal status were studied in mice with cardiac overexpression of ß2-adrenergic receptors (ARs) over 6–15 months (mo) of age. Survival to 15 mo was 96% in wild-type mice but was poorer in transgenic (TG) mice and lower for males than females (13% vs. 56%, P < 0.001). Echocardiography demonstrated progressive left ventricular (LV) dilatation and reduction in LV fractional shortening in male but much less marked changes in female TG mice. Incidences of atrial thrombosis, pleural effusion and lung congestion were higher and myocyte size and fibrosis in the LV were greater in TG males than females. Deprivation of testicular hormones by castration during 3–15 mo of age improved survival and significantly ameliorated LV dysfunction, remodeling, and hypertrophy compared with intact TG males. No significant effect, except for a trend of a better survival, was detected by ovariectomy in TG females. In conclusion, cardiac ß2-AR overexpression at a high level leads to cardiomyopathy and heart failure with aging. Female mice had less cardiac remodeling, dysfunction, and pathology and a marked survival advantage over male mice, and this was independent of prevailing levels of ovarian hormones. TG males showed benefit from orchiectomy, suggesting a contribution by testicular hormones to the progression of the cardiomyopathic phenotype.




This article has been cited by other articles:


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
Y. Yang, Y. Ma, W. Han, J. Li, Y. Xiang, F. Liu, X. Ma, J. Zhang, Z. Fu, Y.-D. Su, et al.
Age-related differences in postinfarct left ventricular rupture and remodeling
Am J Physiol Heart Circ Physiol, April 1, 2008; 294(4): H1815 - H1822.
[Abstract] [Full Text] [PDF]


Home page
Physiol. GenomicsHome page
G. E. Haddad, L. J. Saunders, S. D. Crosby, M. Carles, F. del Monte, K. King, M. R. Bristow, F. G. Spinale, T. E. Macgillivray, M. J. Semigran, et al.
Human cardiac-specific cDNA array for idiopathic dilated cardiomyopathy: sex-related differences
Physiol Genomics, April 1, 2008; 33(2): 267 - 277.
[Abstract] [Full Text] [PDF]


Home page
HeartHome page
C.-W. Siu, C.-Y. Yeung, C.-P. Lau, A. W C Kung, and H.-F. Tse
Incidence, clinical characteristics and outcome of congestive heart failure as the initial presentation in patients with primary hyperthyroidism
Heart, April 1, 2007; 93(4): 483 - 487.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
E. D. Lekgabe, S. G. Royce, T. D. Hewitson, M. L. K. Tang, C. Zhao, X. L. Moore, G. W. Tregear, R. A. D. Bathgate, X.-J. Du, and C. S. Samuel
The Effects of Relaxin and Estrogen Deficiency on Collagen Deposition and Hypertrophy of Nonreproductive Organs
Endocrinology, December 1, 2006; 147(12): 5575 - 5583.
[Abstract] [Full Text] [PDF]


Home page
Clin Med ResHome page
C. S. Samuel
Relaxin: Antifibrotic Properties and Effects in Models of Disease
Clin. Med. Res., November 1, 2005; 3(4): 241 - 249.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
P. Bridgman, M. A. Aronovitz, R. Kakkar, M. I. Oliverio, T. M. Coffman, W. M. Rand, M. A. Konstam, M. E. Mendelsohn, and R. D. Patten
Gender-specific patterns of left ventricular and myocyte remodeling following myocardial infarction in mice deficient in the angiotensin II type 1a receptor
Am J Physiol Heart Circ Physiol, August 1, 2005; 289(2): H586 - H592.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
X.-M. Gao, H. Kiriazis, X.-L. Moore, X.-H. Feng, K. Sheppard, A. Dart, and X.-J. Du
Regression of pressure overload-induced left ventricular hypertrophy in mice
Am J Physiol Heart Circ Physiol, June 1, 2005; 288(6): H2702 - H2707.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
C. S. Samuel, E. N. Unemori, I. Mookerjee, R. A. D. Bathgate, S. L. Layfield, J. Mak, G. W. Tregear, and X.-J. Du
Relaxin Modulates Cardiac Fibroblast Proliferation, Differentiation, and Collagen Production and Reverses Cardiac Fibrosis in Vivo
Endocrinology, September 1, 2004; 145(9): 4125 - 4133.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
X.-J. Du
Gender modulates cardiac phenotype development in genetically modified mice
Cardiovasc Res, August 15, 2004; 63(3): 510 - 519.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
M. C. Rhodes, F. J. Seidler, A. Abdel-Rahman, C. A. Tate, A. Nyska, H. L. Rincavage, and T. A. Slotkin
Terbutaline Is a Developmental Neurotoxicant: Effects on Neuroproteins and Morphology in Cerebellum, Hippocampus, and Somatosensory Cortex
J. Pharmacol. Exp. Ther., February 1, 2004; 308(2): 529 - 537.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 2003 by The Endocrine Society